TfR-T12 TFA is a potent and selective inhibitor used in the biomedical industry to target the transferrin receptor (TfR) to treat iron deficiency related diseases such as anemia. This product aids in regulating iron homeostasis by blocking the binding of transferrin to the TfR, resulting in decreased iron uptake by cells.
CAT# | GR2192 |
M.F/Formula | C73H100F3N19O17S |
M.W/Mr. | 1604.75 |
Appearance | Solid |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
PM102 is a novel synthetic peptide that effectively reverses the anticoagulant effect of heparin. It can be used ...
Zonisamide, sold as brand name Zonegran, is a derivative of 3-(sulfamoylmethyl)-l,2-benzisoxazole. It is a membe ...
The cyclopentapeptide FC 131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-), 2-Nal=3-(2-naphthyl) alanine)) is an ...
Somatostatin is the main hemostatic drug in the clinic, and its derivative octreotide has been confirmed by many ...
Rotigaptide is a novel antiarrhythmic peptide that enhances gap junction (GJ) intercellular conductance between cardiomyocy ...